170 related articles for article (PubMed ID: 36992402)
61. Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab-refractory follicular lymphoma patients in the GADOLIN phase III study.
Gibiansky E; Gibiansky L; Buchheit V; Frey N; Brewster M; Fingerle-Rowson G; Jamois C
Br J Clin Pharmacol; 2019 Sep; 85(9):1935-1945. PubMed ID: 31050355
[TBL] [Abstract][Full Text] [Related]
62. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
Chen J; Niu Z; Li H; Tang D; Zhang P
Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
[TBL] [Abstract][Full Text] [Related]
63. Organizing pneumonia following Covid19 pneumonia.
Funk GC; Nell C; Pokieser W; Thaler B; Rainer G; Valipour A
Wien Klin Wochenschr; 2021 Sep; 133(17-18):979-982. PubMed ID: 33861398
[TBL] [Abstract][Full Text] [Related]
64. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P
Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121
[TBL] [Abstract][Full Text] [Related]
65. Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort-Arkansas, June-August 2020.
Brown NE; Lyons AK; Schuh AJ; Stumpf MM; Harcourt JL; Tamin A; Rasheed MAU; Mills L; Lester SN; Thornburg NJ; Nguyen K; Costantini V; Vinjé J; Huang JY; Gilbert SE; Gable P; Bollinger S; Sabour S; Beshearse E; Surie D; Biedron C; Gregory CJ; Clemmons NS; Whitaker B; Coughlin MM; Seely KA; Garner K; Gulley T; Haney T; Kothari A; Patil N; Halpin AL; McDonald LC; Kutty PK; Brown AC
Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1610-1617. PubMed ID: 34802478
[TBL] [Abstract][Full Text] [Related]
66. Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid.
Takumida H; Izumi S; Sakamoto K; Hashimoto M; Ishii S; Suzuki M; Takasaki J; Tanaka M; Igari T; Hojo M
Respir Investig; 2021 May; 59(3):377-381. PubMed ID: 33547007
[TBL] [Abstract][Full Text] [Related]
67. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
[TBL] [Abstract][Full Text] [Related]
68. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
[TBL] [Abstract][Full Text] [Related]
69. Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up.
Ye X; Xiao X; Li B; Zhu W; Li Y; Wu J; Huang X; Jin J; Chen D; Jin J; Huang J
Front Oncol; 2020; 10():1272. PubMed ID: 32719750
[No Abstract] [Full Text] [Related]
70. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
[TBL] [Abstract][Full Text] [Related]
71. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY
Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030
[TBL] [Abstract][Full Text] [Related]
72. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
73. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
[TBL] [Abstract][Full Text] [Related]
74. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
[TBL] [Abstract][Full Text] [Related]
75. Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.
Tang H; Tian JB; Dong JW; Tang XT; Yan ZY; Zhao YY; Xiong F; Sun X; Song CX; Xiang CG; Tu C; Lei CT; Liu J; Su H; Huang J; Qiu Y; Miao XP; Zhang C
Am J Kidney Dis; 2020 Oct; 76(4):490-499.e1. PubMed ID: 32628990
[TBL] [Abstract][Full Text] [Related]
76. Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment.
Ertesvåg NU; Sakkestad ST; Zhou F; Hoff I; Kristiansen T; Jonassen TM; Follesø E; Brokstad KA; Dyrhovden R; Mohn KG
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016378
[No Abstract] [Full Text] [Related]
77. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A; Shahriari M; Bordbar MR; Hedayati SB; Ziyaeyan M; Jamalidoust M; Kalani M; Heydari Marandi N
J Med Case Rep; 2023 Feb; 17(1):66. PubMed ID: 36765433
[TBL] [Abstract][Full Text] [Related]
78. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.
Möhn N; Pul R; Kleinschnitz C; Prüss H; Witte T; Stangel M; Skripuletz T
Front Immunol; 2020; 11():1059. PubMed ID: 32477373
[TBL] [Abstract][Full Text] [Related]
79. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
Liu X; Cao W; Li T
Front Immunol; 2020; 11():1660. PubMed ID: 32760407
[TBL] [Abstract][Full Text] [Related]
80. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
